MedTrace Logo

Evaluation and Comparison of Women Pelvic Floor With and Without Sexual Dysfunction (Vaginismus)

NCT03176069 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-10-07

No results posted yet for this study

Summary

Sexuality is considered one of the pillars of quality of life, an integral part of the personality of each individual. Being a basic human being need, it cannot be separated from other aspects of life. For several centuries and until recently, sexuality was considered the "lower instincts" expression related only to the sexual act. Sex is associated with "reproduction" of the sexual energy. On the other hand, the exercise of sexuality includes various factors such as the building of the sensitivity between individuals like touch, dance, fantasy, look, etc. For a long time feminine sexuality was predominantly focused on procreation and has only recently been considered as an integral part of sexual and reproductive rights of women. Vaginismus is a female sexual dysfunction that affects the quality of sexual and psychosocial lives of women, influencing the quality of the couple's relationship. The scientific literature emphasizes the importance of the examination, diagnosis and physical therapy for this dysfunction, but until now there is no quantification or evaluation of the pelvic floor muscles for this group of women, which justifies the realization of this project.

Conditions

  • Vaginismus
  • Sexual Dysfunctions
  • Muscular Hypertonicity
  • Muscle Tone Poor

Interventions

OTHER

Evaluation and Comparison of women pelvic floor with and without sexual dysfunction

Pelvic floor muscles will also be evaluated by electromyographic biofeedback.

OTHER

The physiotherapeutic treatment

The available treatment tools are educational, behavioral and rehabilitating. The physiotherapeutic treatment will consist of the following features: * Kinesiotherapy * Manual therapy * Electrotherapy (electric electrostimulation, ultrasound) * Behavioral therapy

Sponsors & Collaborators

  • Faculdade de Ciências Médicas da Santa Casa de São Paulo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2019-06-03
Completion
2019-06-03

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03176069 on ClinicalTrials.gov